01 July 1999
Effect of estradiol and norethisterone replacement therapy on the pharmacokinetics of phenazone
Jerzy Wójcicki, Igor Łoniewski, Jerzy Łokociejewski, Marek Drozdzik, Barbara Gawrońska-SzklarzMed Sci Monit 1999; 5(4): PI754-757 :: ID: 504661
Abstract
The aim of this study was to determine whether short term replacement therapy with estradiol and norethisterone affect the pharmacokinetics of phenazone. The study group comprised of 10 women, aged between 38-62 years, at least six weeks following ovariectomy. Each patient received estradiol (transdermally, 4 mg plaster every 3 days) for a period of 18 days, and subsequently norethisterone (orally, 5 mg per day) for 10 days, with an interval of one day. Pharmacokinetic studies were performed 3 times: prior to estradiol administration, on the last day of estradiol treatment and on the last day of norethisterone administration. Pharmacokinetic assays were performed following a single, oral administration of phenazone at a dose of 1.0 g, followed by blood sampling fora period of 24 hours, in order to determine plasma phenazone concentration levels. Brodi's method was applied for the measurement of phenazone concentrations. The one-compartment open model for extravascular administration was used for the calculations of pharmacokinetic parameters. Short-term administration of estradiol did not significantly alter pharmacokinetic parameter valuess determined during the study. Hormonal replacement therapy with norethisterone does not modify the pharmacokinetics of phenazone. Hormonal replacement therapy with both estradiol and norethisterone does not affect the biotransformation of phenazone.
Keywords: phenazone pharmacokinetics, norethisterone, hormonal replacement therapy
Editorial
01 November 2024 : Editorial
Editorial: Artificial Intelligence (AI), Digital Image Analysis, and the Future of Cancer Diagnosis and PrognosisDOI: 10.12659/MSM.947038
Med Sci Monit 2024; 30:e947038
In Press
Clinical Research
Clinical Outcomes of Talus Bone Marrow Edema: Comparing Plaster Cast, Crutches, and Walking Boot TreatmentsMed Sci Monit In Press; DOI: 10.12659/MSM.946072
Review article
Comprehensive Insights into Arecoline Hydrobromide: Pharmacology, Toxicity, and PharmacokineticsMed Sci Monit In Press; DOI: 10.12659/MSM.945582
Clinical Research
Iliac Periosteal Bone Autografting vs Talus Non-Weight-Bearing Surgery in Hepple V Talus Osteochondral Inju...Med Sci Monit In Press; DOI: 10.12659/MSM.944912
Clinical Research
Impact of Different Orthodontic Appliances on Mandibular Condyle, Anterior Region of Mandibular, and Maxill...Med Sci Monit In Press; DOI: 10.12659/MSM.946265
Most Viewed Current Articles
17 Jan 2024 : Review article 6,335,406
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research 1,908,931
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 695,409
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
07 Jan 2022 : Meta-Analysis 260,542
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...DOI :10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074